Navigation Links
Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth
Date:8/21/2014

NEW YORK, Aug. 21, 2014 /PRNewswire/ -- Mathematic studies at the Program for Evolutionary Dynamics (PED) at Harvard University, and funded by the Jeffrey Epstein VI Foundation, have shown that the most aggressive cells within tumors can be visually identified for elimination. These aggressive cells are the driver mutations that drive the tumor's growth. The study, which shows a topological map of what to look for when examining tumors, comes at a needed time in cancer research, for while tumor cells can be extracted from biopsy, it's very difficult to know which cells are actually causing the growth. And for inhibitor drugs to work, they have to target the most genetically aggressive cancer cells, amongst others.

The Program, or PED, studies the evolution of living systems with the use of mathematics. Much of their work focuses on the evolution of cancer and has significantly impacted treatment at universities across the country. Funding their work is an inscrutable New York private fund manager, called Jeffrey Epstein. Epstein established the PED in 2003 with a $30 million dollar gift to the university and his science foundation is one of the largest donors to individual scientists around the world including a list of luminaries such as Stephen Hawking and Nobel laureates, Gerard 't Hooft, David Gross and Frank Wilczek.

One of the great challenges of cancer is that tumors are genetically diverse, making it extremely difficult to tackle them with tailored inhibitor drugs. In 2010, the PED showed that even small solid tumors contain at least 40 to 100 genetic mutations within its structure, and that only 5 to 15 of those actually drive tumor growth. The findings highlighted the urgency for better genetic profiling of tumor masses beyond random excision, and the need to pinpoint the minority of tumor cell aggressors.

The PED's spatial modeling of how tumors grow however, now offers the first mathematically proven map of how to visually target the key aggressors within a tumor.

"Mathematics in medical research reveals patterns that are otherwise hidden and it's exhilarating when a mathematician can determine cellular behavior with the precision of an engineer," Jeffrey Epstein asserted.


'/>"/>
SOURCE www.jeffreyepstein.org
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research
2. Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science
3. Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research
4. Pressure BioSciences, Inc. Reports Second Quarter 2014 Financial Results and Provides Business Update
5. Leading ALS Researcher Joins the Kansas City University of Medicine and Biosciences
6. Bode Technology Sponsors Houston Forensic Science Center Event
7. UAS LifeSciences to Donate to Women’s Non-Profit of Your Choice
8. Feist-Weiller Cancer Center Partners With Caris Life Sciences to Establish a Clinical Molecular Profiling Program
9. Regado Biosciences Announces Second Quarter 2014 Financial Results and Corporate Highlights
10. Agricultural Science Makes Organic Connection
11. Roka Bioscience Reports Second Quarter 2014 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... DUBLIN , Feb. 10, 2016  Allergan plc ... today announced that Brent Saunders , Allergan,s CEO ... in a fireside chat session at the RBC Capital ... 12:30 p.m. ET at The New York Palace Hotel ... presentation will be webcast live and can be accessed ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor Exhibition on ... fill more than 100 tables for its annual event, which will run from ...
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads ... built on the secure online PatientCrossroads platform, has exceeded both its one-year and ... joined the PROMPT study, which seeks to advance understanding of the hereditary risks ...
(Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an emerging biopharmaceutical ... Alzheimer’s disease, announced today it has been selected to present at the Cavendish Global ... Palm Beach, Florida. The purpose of the Forum is to help family offices ...
Breaking Biology Technology:
(Date:2/3/2016)... 3, 2016 --> ... report "Automated Fingerprint Identification System Market by Component (Hardware ... (Banking & Finance, Government, Healthcare, and Transportation) and Geography ... market is expected to be worth USD 8.49 Billion ... 2015 and 2020. The transformation and technology evolution from ...
(Date:2/2/2016)... Feb. 2, 2016 This BCC Research ... market by reviewing the recent advances in high ... drive the field forward. Includes forecast through 2019. ... the challenges and opportunities that exist in the ... solution developers, as well as IT and bioinformatics ...
(Date:2/2/2016)... Calif. , Feb. 2, 2016  Based ... market, Frost & Sullivan recognizes US-based Intelligent Retinal ... Frost & Sullivan Award for New Product Innovation. ... in North America , is ... the rapidly growing diabetic retinopathy market. The IRIS ...
Breaking Biology News(10 mins):